AURORA CANNABIS INC (ACB) Form 6-K — Nov 4, 2026
Aurora Cannabis has signed a definitive arrangement agreement to be acquired by Organigram, with Aurora shareholders to receive C$7.80 per share in total consideration via cash, 5.8626 Organigram shares, or a C$3.75-plus-shares combination, valuing Aurora at approximately C$561 million on a fully diluted basis. The boards of both companies unanimously recommend the deal, which emerged from a strategic review triggered in part by Curaleaf's ongoing hostile takeover bid. Following closing, expected in January 2027, Aurora shareholders would hold roughly 35% of the economic interest and 42% of the voting interest in the combined company.
Key figures
- Deal Value Usd
- C$561 million (fully diluted equity value)
- Outside date
- May 2, 2027
- Max cash pool
- C$253,638,772
- Expected closing
- January 2027
- Atb debt commitment
- C$210 million
- Share exchange ratio
- 5.8626
- Bat equity commitment
- C$187.5 million (minimum) at C$1.33 per share
- Max organigram shares
- 205,826,172
- Aurora termination fee
- $25,200,000
- Combined consideration
- C$3.75 cash plus 3.0431 Organigram shares per Aurora share
- Organigram expense fee
- $5,600,000
- Shareholder vote threshold
- 66 2/3% of votes cast
- Cash consideration per share
- C$7.80
- Organigram reverse termination fee
- $38,400,000
- Aurora shareholder ownership of combined
- approximately 35% economic / 42% voting
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.